CHENGDU, CHINA, September 29, 2020 – four vehicle-mounted nucleic acid testing labs, co-developed by BGI_MGI and Shudu Bus, are ready to launch in Sichun. They are equipped with MGI’s automation equipment and intelligent laboratory management system, and it only takes four persons to achieve a daily throughput of up to 20,000, making them one of the currently most efficient and movable solutions on the market. The Mobile PCR Lab will be officially launched and delivered to key medical an...

BGI & MGI provide founding member Task Force Lab (TFL) immediate access to US FDA EUA COVID-19 testing equipment and reagents to ramp up capacity and reduce turnaround times San Jose, Calif. – September 22, 2020 – Today, BGI and MGI announced a clinical lab partnership program designed to accelerate population-level testing to help fight the on-going pandemic. The companies are leading global suppliers of COVID-19 (SARS-CoV-2) RT-PCR test kits and automated sample preparation systems, i...

Recently, China’s National Medical Products Administration officially released the “Standards for High-throughput Sequencers” (No. YY/T 1723-2020), which is the first national standard for gene sequencing in the medical device industry and the first international standard for gene sequencers, demonstrating China's forward-looking and advancement in the field of gene sequencing. The standard was initiated by National Institutes for Food and Drug Control (Center for Medical Device Standa...

MGI is partnering with SIMED Peru to provide COVID-19 testing solutions for UNILABS and INS (Peru’s National Institute of Health) to meet demand for timely testing and reliable results at scale. Since the first case of COVID-19 was confirmed in March, the disease has spread in the country rapidly. On March 22, Peruvian President Martín Vizcarra set a daily testing capacity goal of 5,000. A molecular preventive laboratory was proposed, but the country’s Ministry of Health has now prior...

On September 1st, JMDNA (Shanghai) Bio-Medical Tech Co., Ltd. (JMDNA) and Shenzhen MGI Tech Co., Ltd. (MGI) held a cooperation signing ceremony and officially unveiled the first High-throughput Sequencing Technology Innovation and Application Demonstration Center in China. The Center will provide integrated high-throughput sequencing service in the Yangtze River Delta, a region including Shanghai, southern Jiangsu province and northern Zhejiang province, using the world’s highest-daily-th...

On August 31, Shenzhen Haplox Biotechnology Co., Ltd. (Haplox) and Shenzhen MGI Technology Co., Ltd. (MGI) officially announced their cooperation. Xu Mingyan, founder and CEO of Haplox, Yu Dejian, President of MGI, and other representatives attended the signing ceremony. According to the agreement, Haplox will build on the technical advantages of MGI’s DNBSEQ high-throughput sequencing platform and combine its own technologies in the fields of liquid biopsy, biological information and big...